Latest Video

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Under the agreement, Havn Life Sciences will source naturally-derived psychedelic compounds, such as psilocybin, for use in future investigational new drug enabling studies and clinical trials under FDA guidelines.

Tags:

psilocin pharma bucillamine autoimmune hepatitis a rare liver disease cannabinoid orphan drug fast track natural health care plants and fungi psychoactive compounds psilocybin psychedelic compounds havn life sciences inc research and development life sciences

Categories

Other Recent Videos

Great Atlantic to start drilling on 100% owned Golden Promise Gold Property in Central Newfoundland	TAKESTOCK LIVE – Webinar ~ October 14th, 2020	Asante Gold Corporation (CSE:ASE) Announced a Non-Brokered Private Placement
Ximen Mining has received assay results from field examinations completed at the Providence Property	Blockchain Interviews with Jason Eisen, the CEO & Founder of UTU	Blockchain Interviews with Jeff Booth, Tech Entrepreneur and Author of Price of Tomorrow
Blockchain Interviews with Lucas Huang, Head of Growth of at Tokenlon	Blockchain Interviews with Gunnar Jaerv, COO of First Digital Trust	Fremont Gold (TSXV: FRE) Announced a Non-Brokered Private Placement
Eskay Mining completes Productive TV-JEFF Diamond Drill Campaign in Golden Triangle, British Columbia	Hill Street Beverage contracts with Molecule Holdings to produce cannabis infused beverages	Skarb Exploration (CSE:SKRB) has Announced a non-brokered Private Placement

Featured

Great Atlantic to start drilling on 100% owned Golden Promise Gold Property in Central Newfoundland

Asante Gold Corporation (CSE:ASE) Announced a Non-Brokered Private Placement

Ximen Mining has received assay results from field examinations completed at the Providence Property

Reuters